Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Gabapentin Enacarbil in RLS
NCT02117076Phase 4Terminated
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin enacarbil in restless legs syndrome (RLS) (2 arms). Primary endpoint: International Restless Leg Syndrome Rating Scale at 10 weeks. Started Apr 2014; status: terminated.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02117076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117076.